Highly variable timing renders immunotherapy efficacy and toxicity impractical biomarkers of one another in clinical practice
Article in Frontiers in Immunology (April 2024)
The most recent citing publications are shown below. View all 23 publications that cite this research output on Dimensions.
Overnight fasting before lapatinib administration to breast cancer patients leads to reduced toxicity compared with nighttime dosing: a retrospective cohort study from a randomized clinical trial
Article in Cancer Medicine (October 2020)
Towards Rational Cancer Therapeutics: Optimizing Dosing, Delivery, Scheduling, and Combinations
Article in Clinical Pharmacology & Therapeutics (August 2020)